AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+10.6%
5Y CAGR+6.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+10.6%/yr
vs +9.3%/yr prior
5Y CAGR
+6.6%/yr
Recent acceleration
Acceleration
+1.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$317.24B+9.4%
2024$290.02B+16.7%
2023$248.55B+6.0%
2022$234.55B-5.3%
2021$247.75B+7.3%
2020$230.99B+18.1%
2019$195.64B+18.8%
2018$164.63B+10.2%
2017$149.33B+8.1%
2016$138.16B-